Publications by authors named "Ci-Liang Jin"

Crohn's disease (CD) is caused by immune, environmental, and genetic factors. It can involve the entire gastrointestinal tract, and although its prevalence is rapidly increasing its etiology remains unclear. Emerging biological and small-molecule drugs have advanced the treatment of CD; however, a considerable proportion of patients are non-responsive to all known drugs.

View Article and Find Full Text PDF

Background: Currently, there are no drugs that have been proven to be effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Because of its broad antiviral activity, interferon (IFN) should be evaluated as a potential therapeutic agent for treatment of coronavirus disease 2019 (COVID-19), especially while COVID-19-specific therapies are still under development.

Methods: Confirmed COVID-19 patients hospitalized in the First Affiliated Hospital, School of Medicine, Zhejiang University in Hangzhou, China, from January 19 to February 19, 2020 were enrolled in a retrospective study.

View Article and Find Full Text PDF

Background: The outbreak of coronavirus disease 2019 (COVID-19) is now becoming an enormous threat to public health. The clinical spectrum of COVID-19 is extensive, of which critical cases are with rapid disease progression and high mortality. The aim of our study is to summarize the characteristics of different subtypes and explore risk factors of illness severity for early identification and prompt treatment.

View Article and Find Full Text PDF

Introduction: Elevated liver enzyme levels are observed in patients with coronavirus disease 2019 (COVID-19); however, these features have not been characterized.

Methods: Hospitalized patients with COVID-19 in Zhejiang Province, China, from January 17 to February 12, 2020, were enrolled. Liver enzyme level elevation was defined as alanine aminotransferase level >35 U/L for men and 25 U/L for women at admission.

View Article and Find Full Text PDF
Article Synopsis
  • * Data was collected from confirmed COVID-19 cases between January 17 and February 7, 2020, revealing that control patients were older and had a higher clustered onset rate than those exposed to Wuhan.
  • * Symptoms varied between the groups, with higher instances of sore throat in the exposure group and headaches more common in the control group, but overall severity of COVID-19 did not differ significantly between them.
View Article and Find Full Text PDF
Article Synopsis
  • A study analyzed 74 confirmed COVID-19 cases with gastrointestinal (GI) symptoms in Zhejiang province, focusing on their epidemiological, clinical, and virological characteristics.
  • Out of 651 patients, 11.4% exhibited GI symptoms like nausea, vomiting, or diarrhea, with a notable correlation to more severe illness and family clustering.
  • The study highlights the need for healthcare providers to pay attention to non-classical COVID-19 symptoms, as GI-related symptoms can indicate more severe cases and were associated with specific risk factors.
View Article and Find Full Text PDF

Particulate matter (PM) is able to induce airway epithelial injury, while the detailed mechanisms remain unclear. Here we demonstrated that PM exposure inactivated MTOR (mechanistic target of rapamycin kinase), enhanced macroautophagy/autophagy, and impaired lysosomal activity in HBE (human bronchial epithelial) cells and in mouse airway epithelium. Genetic or pharmaceutical inhibition of MTOR significantly enhanced, while inhibition of autophagy attenuated, PM-induced IL6 expression in HBE cells.

View Article and Find Full Text PDF